Cargando…
Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma
BACKGROUND: Papillary thyroid carcinoma (PTC) has a favorable prognosis following one-stage surgical therapy, whereas two-stage resections bear the risk of increased morbidity and possibly impaired prognosis. To further elucidate the value of surgical re-exploration in PTC, a retrospective study was...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817731/ https://www.ncbi.nlm.nih.gov/pubmed/31709300 http://dx.doi.org/10.1515/iss-2018-0023 |
_version_ | 1783463485724688384 |
---|---|
author | Baerbock, Nenia Mittelstädt, Anke Jähne, Joachim |
author_facet | Baerbock, Nenia Mittelstädt, Anke Jähne, Joachim |
author_sort | Baerbock, Nenia |
collection | PubMed |
description | BACKGROUND: Papillary thyroid carcinoma (PTC) has a favorable prognosis following one-stage surgical therapy, whereas two-stage resections bear the risk of increased morbidity and possibly impaired prognosis. To further elucidate the value of surgical re-exploration in PTC, a retrospective study was performed. METHODS: The study involved 187 patients with PTC who underwent total thyroidectomy with central lymph node dissection between 2001 and 2011. The number of two-stage surgeries, the rates of recurrent laryngeal nerve paralysis (RLNP) as well as hypocalcemia, and the long-term survival were assessed. RESULTS: Two-stage surgeries were performed in 43%. No statistically significant difference was seen between the one- and two-stage resection groups regarding the rate of RLNP (transient 5.6% vs. 6.3%, permanent 2.6% vs. 0%) nor for hypocalcemia (transient 25.2% vs. 18.8%, permanent 14.0% vs. 22.5%). The 10-year recurrence-free survival was 95.5% and the 10-year disease-specific survival was 98.9% with no difference between groups. CONCLUSION: Even though two-stage surgeries do not lead to a higher incidence of RLNP and hypocalcemia, optimal preoperative and intraoperative diagnostics have to be carried out to reduce the amount of completion surgeries. |
format | Online Article Text |
id | pubmed-6817731 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | De Gruyter |
record_format | MEDLINE/PubMed |
spelling | pubmed-68177312019-11-08 Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma Baerbock, Nenia Mittelstädt, Anke Jähne, Joachim Innov Surg Sci Original Articles BACKGROUND: Papillary thyroid carcinoma (PTC) has a favorable prognosis following one-stage surgical therapy, whereas two-stage resections bear the risk of increased morbidity and possibly impaired prognosis. To further elucidate the value of surgical re-exploration in PTC, a retrospective study was performed. METHODS: The study involved 187 patients with PTC who underwent total thyroidectomy with central lymph node dissection between 2001 and 2011. The number of two-stage surgeries, the rates of recurrent laryngeal nerve paralysis (RLNP) as well as hypocalcemia, and the long-term survival were assessed. RESULTS: Two-stage surgeries were performed in 43%. No statistically significant difference was seen between the one- and two-stage resection groups regarding the rate of RLNP (transient 5.6% vs. 6.3%, permanent 2.6% vs. 0%) nor for hypocalcemia (transient 25.2% vs. 18.8%, permanent 14.0% vs. 22.5%). The 10-year recurrence-free survival was 95.5% and the 10-year disease-specific survival was 98.9% with no difference between groups. CONCLUSION: Even though two-stage surgeries do not lead to a higher incidence of RLNP and hypocalcemia, optimal preoperative and intraoperative diagnostics have to be carried out to reduce the amount of completion surgeries. De Gruyter 2019-03-27 /pmc/articles/PMC6817731/ /pubmed/31709300 http://dx.doi.org/10.1515/iss-2018-0023 Text en ©2019 Baerbock N., et al., published by De Gruyter, Berlin/Boston http://creativecommons.org/licenses/by/4.0 This work is licensed under the Creative Commons Attribution 4.0 Public License. |
spellingShingle | Original Articles Baerbock, Nenia Mittelstädt, Anke Jähne, Joachim Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma |
title | Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma |
title_full | Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma |
title_fullStr | Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma |
title_full_unstemmed | Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma |
title_short | Morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma |
title_sort | morbidity and long-term survival in patients with cervical re-exploration for papillary thyroid carcinoma |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817731/ https://www.ncbi.nlm.nih.gov/pubmed/31709300 http://dx.doi.org/10.1515/iss-2018-0023 |
work_keys_str_mv | AT baerbocknenia morbidityandlongtermsurvivalinpatientswithcervicalreexplorationforpapillarythyroidcarcinoma AT mittelstadtanke morbidityandlongtermsurvivalinpatientswithcervicalreexplorationforpapillarythyroidcarcinoma AT jahnejoachim morbidityandlongtermsurvivalinpatientswithcervicalreexplorationforpapillarythyroidcarcinoma |